Hyperprogression in cancer patients on immunotherapeutic agents.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.3575
Abstract: 3575Background: Patients (pts) treated with checkpoint inhibitors (CPI) may uncommonly experience accelerated progression in their tumor burden when compared to their rate of progression prior to r... read more here.
Keywords: patients immunotherapeutic; hyperprogression cancer; oncology; cancer patients ... See more keywords
Antimicrobial Peptides As Biologic and Immunotherapeutic Agents against Cancer: A Comprehensive Overview
Sign Up to like & getrecommendations! Published in 2017 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2017.01320
Abstract: Antimicrobial peptides (AMPs) are a pervasive and evolutionarily ancient component of innate host defense which is present in virtually all classes of life. In recent years, evidence has accumulated that parallel or de novo mechanisms… read more here.
Keywords: peptides biologic; agents cancer; biologic immunotherapeutic; antimicrobial peptides ... See more keywords